Part Number
Part Number:
NSN:
NIIN:
Item Name:
CYCLOPHOSPHAMIDE FOR INJECTION , U
Definition:
CAGE Information
| Code | Company |
|---|---|
| 3N559 | ADRIA LABORATORIES INC |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CYCLOPHOSPHAMIDE FOR INJECTION USP 500MG VIAL 12S BX |
| CBBL | FEATURES PROVIDED | STERILE |
| AGXW | PHYSICAL FORM | POWDER |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 12 |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 500.000 MILLIGRAMS ANHYDROUS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 MILLIGRAMS ACTIVE INGREDIENT |
| THPE | THERAPEUTIC EQUIVALENT | NEOSAR BY ABBOTT; CYTOXAN BY BRISTOL LABS |
| CQPQ | WARNING AND CAUTION STATEMENTS | CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE |
| FEAT | SPECIAL FEATURES | VIAL WITH NOT LESS THAN 30 ML CAPACITY |